← Back to Search

Other

Intervention for Health Care Utilization (017744S Trial)

N/A
Recruiting
Research Sponsored by University of Arkansas
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be at least 25 years old
Self-report as having received from a medical professional a diagnosis for HIV
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 year
Awards & highlights

017744S Trial Summary

This trial aims to study the effects of providing a Universal Basic Income (UBI) to Black men living with HIV in Arkansas. The goal is to understand if giving these men a monthly cash transfer of

Who is the study for?
This trial is for Black or African American men, at least 25 years old, living with HIV in central Arkansas. Participants must speak English, consent to the study, plan to stay in the area for the duration of the study, and share weekly employment-seeking activities and financial information. They should have an income up to 400% of the federal poverty threshold.Check my eligibility
What is being tested?
The trial tests if a Universal Basic Income (UBI) of $500 per month for six months can increase healthcare use among low-income Black men with HIV. It aims to see if UBI helps them get better access to care and improves adherence to HIV medication.See study design
What are the potential side effects?
Since this intervention involves financial support rather than medical treatment, there are no direct physical side effects expected from receiving UBI. However, changes in social behavior or stress levels due to economic changes could occur.

017744S Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am at least 25 years old.
Select...
I have been diagnosed with HIV by a healthcare provider.
Select...
My yearly income is within 400% of the federal poverty level.
Select...
I was assigned male at birth.

017744S Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 year
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 year for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Receipt of HIV care
Secondary outcome measures
HIV medication adherence
Reduced HIV risk behaviors, including both unprotected sex and substance use
Retention in HIV care
+1 more

017744S Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: InterventionExperimental Treatment1 Intervention
Participants in Arm 2 will receive a monthly UBI stipend of $500 for 6 months. Study staff will explain that UBI payments will continue for 6 months and that the UBI payments will be suspended if an individual is reincarcerated (e.g. the participant will not receive UBI payments to their ClinCard during months of incarceration and will not receive additional months post-release from incarceration). Participants will receive their monthly UBI payment, along with all study-related compensation for completing baseline and follow-up assessments, through a ClinCard, which is a loadable debit card with an ID number unique to the participant. The UBI will be loaded to the participant's ClinCard on the first day of each month.
Group II: ControlActive Control1 Intervention
All participants will receive the following: 1) a ClinCard and instructions for completing a weekly financial journal to record participants' spending patterns and social needs during the first 6 months of the study; 2) materials about financial literacy and community-based resources that provide support to low-income individuals; 3) description and instructions for follow-up assessments and check-ins; 4) a copy of signed medical release, consent, and HIPAA forms; 5) respondent-driven sampling referral cards; 6) 3 study referral cards, and 7) information about voter registration services provided through the Pulaski County Circuit and County Clerk's Office (https://www.pulaskiclerk.com/voter-registration/). Participants will be provided information about the importance of voting, restoration of voting rights, and the process of voting and sealing records.

Find a Location

Who is running the clinical trial?

University of ArkansasLead Sponsor
486 Previous Clinical Trials
150,273 Total Patients Enrolled
Ashley Williams, MHSStudy DirectorUniversity of Arkansas

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies available for patients to participate in this trial?

"Indeed, according to the details provided on clinicaltrials.gov, this ongoing clinical trial is actively seeking eligible participants. The trial was first posted on April 13th, 2023 and last updated on December 15th, 2023. A total of 80 individuals are being enrolled in this study at a single site."

Answered by AI

What is the upper limit of participants enrolled in this clinical study?

"Indeed, the details provided on clinicaltrials.gov indicate that this investigation is currently actively seeking suitable candidates. The initial posting of the clinical trial occurred on April 13th, 2023 and it was last modified on December 15th, 2023. A total of 80 participants are being sought from a single research site."

Answered by AI
~42 spots leftby Jan 2025